Literature DB >> 31040226

Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.

Joel D Federspiel1, Todd M Greco1, Krystal K Lum1, Ileana M Cristea2.   

Abstract

Huntington's disease (HD) is a monogenic disorder, driven by the expansion of a trinucleotide (CAG) repeat within the huntingtin (Htt) gene and culminating in neuronal degeneration in the brain, predominantly in the striatum and cortex. Histone deacetylase 4 (Hdac4) was previously found to contribute to the disease progression, providing a potential therapeutic target. Hdac4 knockdown reduced accumulation of misfolded Htt protein and improved HD phenotypes. However, the underlying mechanism remains unclear, given its independence on deacetylase activity and the predominant cytoplasmic Hdac4 localization in the brain. Here, we undertook a multiomics approach to uncover the function of Hdac4 in the context of HD pathogenesis. We characterized the interactome of endogenous Hdac4 in brains of HD mouse models. Alterations in interactions were investigated in response to Htt polyQ length, comparing mice with normal (Q20) and disease (Q140) Htt, at both pre- and post-symptomatic ages (2 and 10 months, respectively). Parallel analyses for Hdac5, a related class IIa Hdac, highlighted the unique interaction network established by Hdac4. To validate and distinguish interactions specifically enhanced in an HD-vulnerable brain region, we next characterized endogenous Hdac4 interactions in dissected striata from this HD mouse series. Hdac4 associations were polyQ-dependent in the striatum, but not in the whole brain, particularly in symptomatic mice. Hdac5 interactions did not exhibit polyQ dependence. To identify which Hdac4 interactions and functions could participate in HD pathogenesis, we integrated our interactome with proteome and transcriptome data sets generated from the striata. We discovered an overlap in enriched functional classes with the Hdac4 interactome, particularly in vesicular trafficking and synaptic functions, and we further validated the Hdac4 interaction with the Wiskott-Aldrich Syndrome Protein and SCAR Homolog (WASH) complex. This study expands the knowledge of Hdac4 regulation and functions in HD, adding to the understanding of the molecular underpinning of HD phenotypes.
© 2019 Federspiel et al.

Entities:  

Keywords:  Hdac4; Hdac5; Huntington's Disease; Label-free quantification; Multiomics; Neurodegenerative diseases*; Omics; Protein-Protein Interactions*; Systems biology*; WASH complex

Mesh:

Substances:

Year:  2019        PMID: 31040226      PMCID: PMC6692770          DOI: 10.1074/mcp.RA118.001253

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  79 in total

Review 1.  Class II histone deacetylases: versatile regulators.

Authors:  Eric Verdin; Franck Dequiedt; Herbert G Kasler
Journal:  Trends Genet       Date:  2003-05       Impact factor: 11.639

2.  Sample preparation and digestion for proteomic analyses using spin filters.

Authors:  Linda L Manza; Sheryl L Stamer; Amy-Joan L Ham; Simona G Codreanu; Daniel C Liebler
Journal:  Proteomics       Date:  2005-05       Impact factor: 3.984

3.  Determining the Composition and Stability of Protein Complexes Using an Integrated Label-Free and Stable Isotope Labeling Strategy.

Authors:  Todd M Greco; Amanda J Guise; Ileana M Cristea
Journal:  Methods Mol Biol       Date:  2016

4.  Human Huntington's Disease iPSC-Derived Cortical Neurons Display Altered Transcriptomics, Morphology, and Maturation.

Authors:  Shagun R Mehta; Colton M Tom; Yizhou Wang; Catherine Bresee; David Rushton; Pranav P Mathkar; Jie Tang; Virginia B Mattis
Journal:  Cell Rep       Date:  2018-10-23       Impact factor: 9.423

Review 5.  Striatal synaptic dysfunction and altered calcium regulation in Huntington disease.

Authors:  Lynn A Raymond
Journal:  Biochem Biophys Res Commun       Date:  2016-07-14       Impact factor: 3.575

6.  Cell type- and brain region-resolved mouse brain proteome.

Authors:  Kirti Sharma; Sebastian Schmitt; Caroline G Bergner; Stefka Tyanova; Nirmal Kannaiyan; Natalia Manrique-Hoyos; Karina Kongi; Ludovico Cantuti; Uwe-Karsten Hanisch; Mari-Anne Philips; Moritz J Rossner; Matthias Mann; Mikael Simons
Journal:  Nat Neurosci       Date:  2015-11-02       Impact factor: 24.884

7.  Phosphorylation of mutant huntingtin at serine 116 modulates neuronal toxicity.

Authors:  Erin E Watkin; Nicolas Arbez; Elaine Waldron-Roby; Robert O'Meally; Tamara Ratovitski; Robert N Cole; Christopher A Ross
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

8.  Decreased cohesin in the brain leads to defective synapse development and anxiety-related behavior.

Authors:  Yuki Fujita; Koji Masuda; Masashige Bando; Ryuichiro Nakato; Yuki Katou; Takashi Tanaka; Masahiro Nakayama; Keizo Takao; Tsuyoshi Miyakawa; Tatsunori Tanaka; Yukio Ago; Hitoshi Hashimoto; Katsuhiko Shirahige; Toshihide Yamashita
Journal:  J Exp Med       Date:  2017-04-13       Impact factor: 14.307

9.  Early alteration of epigenetic-related transcription in Huntington's disease mouse models.

Authors:  Irati Hervás-Corpión; Deisy Guiretti; Manuel Alcaraz-Iborra; Román Olivares; Antonio Campos-Caro; Ángel Barco; Luis M Valor
Journal:  Sci Rep       Date:  2018-07-02       Impact factor: 4.379

10.  Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records.

Authors:  Stephen J W Evans; Ian Douglas; Michael D Rawlins; Nancy S Wexler; Sarah J Tabrizi; Liam Smeeth
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-03-12       Impact factor: 10.154

View more
  11 in total

1.  Proteomics Is Not an Island: Multi-omics Integration Is the Key to Understanding Biological Systems.

Authors:  Bing Zhang; Bernhard Kuster
Journal:  Mol Cell Proteomics       Date:  2019-08-09       Impact factor: 5.911

2.  Dynamics of huntingtin protein interactions in the striatum identifies candidate modifiers of Huntington disease.

Authors:  Todd M Greco; Christopher Secker; Eduardo Silva Ramos; Joel D Federspiel; Jeh-Ping Liu; Alma M Perez; Ismael Al-Ramahi; Jeffrey P Cantle; Jeffrey B Carroll; Juan Botas; Scott O Zeitlin; Erich E Wanker; Ileana M Cristea
Journal:  Cell Syst       Date:  2022-02-10       Impact factor: 11.091

3.  Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target.

Authors:  Severin Lechner; Martin Ian P Malgapo; Christian Grätz; Raphael R Steimbach; Agnes Baron; Patrick Rüther; Simon Nadal; Carmen Stumpf; Christina Loos; Xin Ku; Polina Prokofeva; Ludwig Lautenbacher; Tino Heimburg; Vivian Würf; Chen Meng; Mathias Wilhelm; Wolfgang Sippl; Karin Kleigrewe; Josch K Pauling; Karl Kramer; Aubry K Miller; Michael W Pfaffl; Maurine E Linder; Bernhard Kuster; Guillaume Médard
Journal:  Nat Chem Biol       Date:  2022-04-28       Impact factor: 16.174

4.  Evaluation of 5-(Trifluoromethyl)-1,2,4-oxadiazole-Based Class IIa HDAC Inhibitors for Huntington's Disease.

Authors:  Andrew J Stott; Michel C Maillard; Vahri Beaumont; David Allcock; Omar Aziz; Alexander H Borchers; Wesley Blackaby; Perla Breccia; Gillian Creighton-Gutteridge; Alan F Haughan; Rebecca E Jarvis; Christopher A Luckhurst; Kim L Matthews; George McAllister; Scott Pollack; Elizabeth Saville-Stones; Amanda J Van de Poël; Huw D Vater; Julie Vann; Rachel Williams; Dawn Yates; Ignacio Muñoz-Sanjuán; Celia Dominguez
Journal:  ACS Med Chem Lett       Date:  2021-02-11       Impact factor: 4.345

Review 5.  Non-Cell Autonomous and Epigenetic Mechanisms of Huntington's Disease.

Authors:  Chaebin Kim; Ali Yousefian-Jazi; Seung-Hye Choi; Inyoung Chang; Junghee Lee; Hoon Ryu
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

6.  Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation.

Authors:  Xiaoming Liu; Xiang Li; Ling Chen; Alan Chen-Yu Hsu; Kelly L Asquith; Chi Liu; Karen Laurie; Ian Barr; Paul S Foster; Ming Yang
Journal:  Front Immunol       Date:  2022-02-25       Impact factor: 7.561

7.  Cytoplasmic HDAC4 regulates the membrane repair mechanism in Duchenne muscular dystrophy.

Authors:  Alessandra Renzini; Nicoletta Marroncelli; Giorgia Cavioli; Silvia Di Francescantonio; Laura Forcina; Alessandro Lambridis; Eros Di Giorgio; Sergio Valente; Antonello Mai; Claudio Brancolini; Claudia Giampietri; Alessandra Magenta; Francesca De Santa; Sergio Adamo; Dario Coletti; Viviana Moresi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-02-15       Impact factor: 12.910

8.  HDAC4 Knockdown Alleviates Denervation-Induced Muscle Atrophy by Inhibiting Myogenin-Dependent Atrogene Activation.

Authors:  Wenjing Ma; Yong Cai; Yuntian Shen; Xin Chen; Lilei Zhang; Yanan Ji; Zehao Chen; Jianwei Zhu; Xiaoming Yang; Hualin Sun
Journal:  Front Cell Neurosci       Date:  2021-06-30       Impact factor: 5.505

9.  Behavioral Alterations in Mice Carrying Homozygous HDAC4 A778T Missense Mutation Associated With Eating Disorder.

Authors:  Kevin C Davis; Kenji Saito; Samuel R Rodeghiero; Brandon A Toth; Michael Lutter; Huxing Cui
Journal:  Front Neurosci       Date:  2020-02-21       Impact factor: 4.677

10.  Subcellular Localization And Formation Of Huntingtin Aggregates Correlates With Symptom Onset And Progression In A Huntington'S Disease Model.

Authors:  Christian Landles; Rebecca E Milton; Nadira Ali; Rachel Flomen; Michael Flower; Franziska Schindler; Casandra Gomez-Paredes; Marie K Bondulich; Georgina F Osborne; Daniel Goodwin; Grace Salsbury; Caroline L Benn; Kirupa Sathasivam; Edward J Smith; Sarah J Tabrizi; Erich E Wanker; Gillian P Bates
Journal:  Brain Commun       Date:  2020-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.